Markets
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Albany Molecular files Allegra patent lawsuits
ALBANY, N.Y. (AP) — Albany Molecular Research Inc. said Tuesday it filed patent infringement lawsuits against drug developers Dr. Reddy's Laboratories Ltd. and Sandoz Inc. over patents dealing with Sanofi-Aventis' antihistamines Allegra and Allegra D.
Albany Molecular earns royalties from sales of Allegra from Sanofi-Aventis, as well as from the authorized generic. It filed the lawsuits in U.S. District Court in New Jersey, citing plans by Dr. Reddy's and Sandoz to market generic versions of the drugs.
In November, Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc. settled a patent lawsuit with Sanofi-Aventis' over the allergy drugs Allegra and Nasacort. That deal will allow for sales of certain generic doses of the drugs early. Financial details of that settlement were not disclosed.
Shares of Albany Molecular fell 3 cents to $8.08 in morning trading.